United States

Somaxon Pharmaceuticals, Inc. (SOMX)

Track

Track

Ticker: SOMX
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Nguyen Tran SVP and CFO Officer
Transaction date
Planned sale
Price
197.66
Quantity 16,008 +16.3%
Value US$2,543,574
EMSTER KURT VON Non-Executive Director
Transaction date
Sale
Price
341.02
Quantity 32,189 -9.6%
Value US$217,608
MPM BIOVENTURES III-QP L.P. Large shareholder
Transaction date
Sale
Price
448.35
Quantity 52,078 +28.4%
Value US$4,845,125
EVNIN LUKE Large shareholder
Transaction date
Sale
Price
0.31
Quantity 1,624,574 -56.0%
Value US$498,744
MPM BIOVENTURES III-QP L.P. Large shareholder
Transaction date
Sale
Price
0.29
Quantity 671,217 -18.8%
Value US$195,324
EVNIN LUKE Large shareholder
Transaction date
Sale
Price
0.29
Quantity 671,217 -18.8%
Value US$195,324
EVNIN LUKE Large shareholder
Transaction date
Sale
Price
0.29
Quantity 98,210 -2.7%
Value US$28,481
MPM BIOVENTURES III-QP L.P. Large shareholder
Transaction date
Sale
Price
0.29
Quantity 98,210 -2.7%
Value US$28,481
EVNIN LUKE Large shareholder
Transaction date
Sale
Price
0.29
Quantity 80,348 -2.1%
Value US$23,301
MPM BIOVENTURES III-QP L.P. Large shareholder
Transaction date
Sale
Price
0.29
Quantity 80,348 -2.1%
Value US$23,301
MPM BIOVENTURES III-QP L.P. Large shareholder
Transaction date
Sale
Price
0.29
Quantity 19,500 -0.5%
Value US$5,655
EVNIN LUKE Large shareholder
Transaction date
Sale
Price
0.29
Quantity 19,500 -0.5%
Value US$5,655
MPM BIOVENTURES III-QP L.P. Large shareholder
Transaction date
Sale
Price
0.29
Quantity 12,000 -0.3%
Value US$3,480
EVNIN LUKE Large shareholder
Transaction date
Sale
Price
0.29
Quantity 12,000 -0.3%
Value US$3,480
EVNIN LUKE Large shareholder
Transaction date
Sale
Price
0.29
Quantity 1,450 -0.0%
Value US$420
MPM BIOVENTURES III-QP L.P. Large shareholder
Transaction date
Sale
Price
0.29
Quantity 1,450 -0.0%
Value US$420
MPM BIOVENTURES III-QP L.P. Large shareholder
Transaction date
Sale
Price
0.29
Quantity 8,400 -0.2%
Value US$2,436
EVNIN LUKE Large shareholder
Transaction date
Sale
Price
0.29
Quantity 8,400 -0.2%
Value US$2,436
MPM BIOVENTURES III-QP L.P. Large shareholder
Transaction date
Sale
Price
0.29
Quantity 29,555 -0.8%
Value US$8,571
EVNIN LUKE Large shareholder
Transaction date
Sale
Price
0.29
Quantity 29,555 -0.8%
Value US$8,571
MPM BIOVENTURES III-QP L.P. Large shareholder
Transaction date
Sale
Price
0.30
Quantity 29,850 -0.8%
Value US$8,955
EVNIN LUKE Large shareholder
Transaction date
Sale
Price
0.30
Quantity 29,850 -0.8%
Value US$8,955
MPM BIOVENTURES III-QP L.P. Large shareholder
Transaction date
Sale
Price
0.30
Quantity 51,007 -1.3%
Value US$15,302
EVNIN LUKE Large shareholder
Transaction date
Sale
Price
0.30
Quantity 51,007 -1.3%
Value US$15,302
MPM BIOVENTURES III-QP L.P. Large shareholder
Transaction date
Sale
Price
0.30
Quantity 15,300 -0.4%
Value US$4,622
EVNIN LUKE Large shareholder
Transaction date
Sale
Price
0.30
Quantity 15,300 -0.4%
Value US$4,622
MPM BIOVENTURES III-QP L.P. Large shareholder
Transaction date
Sale
Price
0.30
Quantity 293,015 -7.0%
Value US$87,904
EVNIN LUKE Large shareholder
Transaction date
Sale
Price
0.30
Quantity 293,015 -7.0%
Value US$87,904
MPM BIOVENTURES III-QP L.P. Large shareholder
Transaction date
Sale
Price
0.30
Quantity 135,250 -3.1%
Value US$40,629
EVNIN LUKE Large shareholder
Transaction date
Sale
Price
0.30
Quantity 135,250 -3.1%
Value US$40,629
MPM BIOVENTURES III-QP L.P. Large shareholder
Transaction date
Sale
Price
0.30
Quantity 287,000 -6.2%
Value US$86,990
EVNIN LUKE Large shareholder
Transaction date
Sale
Price
0.30
Quantity 287,000 -6.2%
Value US$86,990
Pascoe Richard W President and CEO Executive Director
Transaction date
Purchase
Price
2.25
Quantity 11,100 +5.6%
Value US$24,943
MAST ERLE T Non-Executive Director
Transaction date
Sale
Price
3.23
Quantity 10,000 -15.0%
Value US$32,340
Nguyen Tran Vice President and CFO Officer
Transaction date
Purchase
Price
3.89
Quantity 2,500 +10.0%
Value US$9,725
Dorsey Brian SVP, Technical Operations Officer
Transaction date
Planned sale
Price
4.27
Quantity 3,000 -5.5%
Value US$12,810
Dorsey Brian SVP, Technical Operations Officer
Transaction date
Planned sale
Price
4.99
Quantity 5,000 -8.8%
Value US$24,950
Dorsey Brian SVP, Technical Operations Officer
Transaction date
Planned sale
Price
3.99
Quantity 3,000 -5.5%
Value US$11,970
Dorsey Brian SVP, Technical Operations Officer
Transaction date
Planned sale
Price
3.99
Quantity 3,000 -5.5%
Value US$11,970
Dorsey Brian SVP, Technical Operations Officer
Transaction date
Planned sale
Price
4.48
Quantity 3,795 -100.0%
Value US$17,013
Dorsey Brian SVP, Technical Operations Officer
Transaction date
Planned sale
Price
4.48
Quantity 1,392 -100.0%
Value US$6,240
Dorsey Brian SVP, Technical Operations Officer
Transaction date
Planned sale
Price
4.48
Quantity 1,833 -100.0%
Value US$8,217
Dorsey Brian SVP, Technical Operations Officer
Transaction date
Planned sale
Price
4.48
Quantity 1,412 -100.0%
Value US$6,330
Dorsey Brian SVP, Technical Operations Officer
Transaction date
Planned sale
Price
4.48
Quantity 354 -100.0%
Value US$1,587
Dorsey Brian SVP, Technical Operations Officer
Transaction date
Planned sale
Price
4.48
Quantity 214 -100.0%
Value US$959
Dorsey Brian VP Product Development Officer
Transaction date
Planned sale
Price
9.74
Quantity 500 -5.0%
Value US$4,868
Dorsey Brian VP Product Development Officer
Transaction date
Planned sale
Price
8.78
Quantity 2,800 -22.0%
Value US$24,596
Dorsey Brian VP Product Development Officer
Transaction date
Planned sale
Price
7.92
Quantity 15,900 -55.6%
Value US$125,947
Dorsey Brian VP Product Development Officer
Transaction date
Planned sale
Price
6.67
Quantity 15,800 -35.6%
Value US$105,323
Dorsey Brian VP Product Development Officer
Transaction date
Planned sale
Price
5.23
Quantity 23,000 -34.1%
Value US$120,262
Onaitis Matthew VP, General Counsel Officer
Transaction date
Planned sale
Price
9.00
Quantity 14,454 -32.5%
Value US$130,086
Onaitis Matthew VP, General Counsel Officer
Transaction date
Planned sale
Price
6.59
Quantity 15,000 -25.2%
Value US$98,882
MONTREUX EQUITY PARTNERS II SBIC LP Large shareholder
Transaction date
Sale
Price
6.38
Quantity 1,500,000 -68.3%
Value US$9,573,600
Raser Jeffrey Senior VP, Sales and Marketing Officer
Transaction date
Sale
Price
9.74
Quantity 1,200 -7.4%
Value US$11,682
Raser Jeffrey Senior VP, Sales and Marketing Officer
Transaction date
Sale
Price
8.82
Quantity 6,800 -29.6%
Value US$60,004
Raser Jeffrey Senior VP, Sales and Marketing Officer
Transaction date
Sale
Price
7.84
Quantity 7,500 -24.6%
Value US$58,822
Raser Jeffrey Senior VP, Sales and Marketing Officer
Transaction date
Sale
Price
6.57
Quantity 24,500 -44.5%
Value US$161,053
Raser Jeffrey Senior VP, Sales and Marketing Officer
Transaction date
Planned sale
Price
9.75
Quantity 230 -1.5%
Value US$2,243
Raser Jeffrey Senior VP, Sales and Marketing Officer
Transaction date
Planned sale
Price
8.84
Quantity 2,100 -12.1%
Value US$18,571
Raser Jeffrey Senior VP, Sales and Marketing Officer
Transaction date
Planned sale
Price
7.81
Quantity 2,400 -12.2%
Value US$18,753
Pascoe Richard W President and CEO Executive Director
Transaction date
Sale
Price
9.58
Quantity 1,200 -7.2%
Value US$11,491
Pascoe Richard W President and CEO Executive Director
Transaction date
Sale
Price
8.74
Quantity 2,600 -13.5%
Value US$22,719
Pascoe Richard W President and CEO Executive Director
Transaction date
Sale
Price
7.53
Quantity 4,800 -19.9%
Value US$36,156
Pascoe Richard W President and CEO Executive Director
Transaction date
Sale
Price
6.42
Quantity 15,100 -38.5%
Value US$96,928
Pascoe Richard W President and CEO Executive Director
Transaction date
Sale
Price
5.62
Quantity 76,300 -66.1%
Value US$429,111
Raser Jeffrey Senior VP, Sales and Marketing Officer
Transaction date
Planned sale
Price
4.08
Quantity 84,000 -100.0%
Value US$342,367
Pascoe Richard W President and CEO Executive Director
Transaction date
Planned sale
Price
4.01
Quantity 40,000 -100.0%
Value US$160,524
Onaitis Matthew VP, General Counsel Officer
Transaction date
Planned sale
Price
4.02
Quantity 30,000 -100.0%
Value US$120,465
Dorsey Brian VP Product Development Officer
Transaction date
Planned sale
Price
4.01
Quantity 23,000 -100.0%
Value US$92,179
Dorsey Brian VP Product Development Officer
Transaction date
Planned sale
Price
3.99
Quantity 6,000 -100.0%
Value US$23,940
Dorsey Brian VP Product Development Officer
Transaction date
Planned sale
Price
3.06
Quantity 20,712 -100.0%
Value US$63,368
Raser Jeffrey Senior VP, Sales and Marketing Officer
Transaction date
Planned sale
Price
3.03
Quantity 57,500 -100.0%
Value US$174,306
Pascoe Richard W President and CEO Executive Director
Transaction date
Planned sale
Price
3.03
Quantity 62,000 -100.0%
Value US$187,600
Onaitis Matthew VP, General Counsel Officer
Transaction date
Planned sale
Price
3.03
Quantity 60,000 -100.0%
Value US$181,506
TREU JESSE I Non-Executive Director
Transaction date
Sale
Price
1.10
Quantity 61,308 -100.0%
Value US$67,439
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2013-01-03 2013-01-02 PlS Planned sale Nguyen Tran

SVP and CFO

Officer
16,008 +16.3%
197.66
US$2,543,574 		16,008 +16.3% 197.66 US$2,543,574
2012-09-06 2012-09-05 S Sale EMSTER KURT VON Non-Executive Director
32,189 -9.6%
341.02
US$217,608 		32,189 -9.6% 341.02 US$217,608
2012-07-10 2012-07-09 S Sale MPM BIOVENTURES III-QP L.P. Large shareholder
52,078 +28.4%
448.35
US$4,845,125 		52,078 +28.4% 448.35 US$4,845,125
2012-07-10 2012-07-09 S Sale EVNIN LUKE Large shareholder
1,624,574 -56.0%
0.31
US$498,744 		1,624,574 -56.0% 0.31 US$498,744
2012-07-10 2012-07-06 S Sale MPM BIOVENTURES III-QP L.P. Large shareholder
671,217 -18.8%
0.29
US$195,324 		671,217 -18.8% 0.29 US$195,324
2012-07-10 2012-07-06 S Sale EVNIN LUKE Large shareholder
671,217 -18.8%
0.29
US$195,324 		671,217 -18.8% 0.29 US$195,324
2012-07-05 2012-07-03 S Sale EVNIN LUKE Large shareholder
98,210 -2.7%
0.29
US$28,481 		98,210 -2.7% 0.29 US$28,481
2012-07-05 2012-07-02 S Sale MPM BIOVENTURES III-QP L.P. Large shareholder
98,210 -2.7%
0.29
US$28,481 		98,210 -2.7% 0.29 US$28,481
2012-07-05 2012-07-02 S Sale EVNIN LUKE Large shareholder
80,348 -2.1%
0.29
US$23,301 		80,348 -2.1% 0.29 US$23,301
2012-07-05 2012-07-02 S Sale MPM BIOVENTURES III-QP L.P. Large shareholder
80,348 -2.1%
0.29
US$23,301 		80,348 -2.1% 0.29 US$23,301
2012-07-02 2012-06-28 S Sale MPM BIOVENTURES III-QP L.P. Large shareholder
19,500 -0.5%
0.29
US$5,655 		19,500 -0.5% 0.29 US$5,655
2012-07-02 2012-06-28 S Sale EVNIN LUKE Large shareholder
19,500 -0.5%
0.29
US$5,655 		19,500 -0.5% 0.29 US$5,655
2012-06-21 2012-06-19 S Sale MPM BIOVENTURES III-QP L.P. Large shareholder
12,000 -0.3%
0.29
US$3,480 		12,000 -0.3% 0.29 US$3,480
2012-06-21 2012-06-19 S Sale EVNIN LUKE Large shareholder
12,000 -0.3%
0.29
US$3,480 		12,000 -0.3% 0.29 US$3,480
2012-06-19 2012-06-15 S Sale EVNIN LUKE Large shareholder
1,450 -0.0%
0.29
US$420 		1,450 -0.0% 0.29 US$420
2012-06-19 2012-06-15 S Sale MPM BIOVENTURES III-QP L.P. Large shareholder
1,450 -0.0%
0.29
US$420 		1,450 -0.0% 0.29 US$420
2012-06-07 2012-06-06 S Sale MPM BIOVENTURES III-QP L.P. Large shareholder
8,400 -0.2%
0.29
US$2,436 		8,400 -0.2% 0.29 US$2,436
2012-06-07 2012-06-06 S Sale EVNIN LUKE Large shareholder
8,400 -0.2%
0.29
US$2,436 		8,400 -0.2% 0.29 US$2,436
2012-06-07 2012-06-05 S Sale MPM BIOVENTURES III-QP L.P. Large shareholder
29,555 -0.8%
0.29
US$8,571 		29,555 -0.8% 0.29 US$8,571
2012-06-07 2012-06-05 S Sale EVNIN LUKE Large shareholder
29,555 -0.8%
0.29
US$8,571 		29,555 -0.8% 0.29 US$8,571
2012-06-04 2012-05-31 S Sale MPM BIOVENTURES III-QP L.P. Large shareholder
29,850 -0.8%
0.30
US$8,955 		29,850 -0.8% 0.30 US$8,955
2012-06-04 2012-05-31 S Sale EVNIN LUKE Large shareholder
29,850 -0.8%
0.30
US$8,955 		29,850 -0.8% 0.30 US$8,955
2012-06-04 2012-05-30 S Sale MPM BIOVENTURES III-QP L.P. Large shareholder
51,007 -1.3%
0.30
US$15,302 		51,007 -1.3% 0.30 US$15,302
2012-06-04 2012-05-30 S Sale EVNIN LUKE Large shareholder
51,007 -1.3%
0.30
US$15,302 		51,007 -1.3% 0.30 US$15,302
2012-06-04 2012-05-29 S Sale MPM BIOVENTURES III-QP L.P. Large shareholder
15,300 -0.4%
0.30
US$4,622 		15,300 -0.4% 0.30 US$4,622
2012-06-04 2012-05-29 S Sale EVNIN LUKE Large shareholder
15,300 -0.4%
0.30
US$4,622 		15,300 -0.4% 0.30 US$4,622
2012-06-04 2012-05-25 S Sale MPM BIOVENTURES III-QP L.P. Large shareholder
293,015 -7.0%
0.30
US$87,904 		293,015 -7.0% 0.30 US$87,904
2012-06-04 2012-05-25 S Sale EVNIN LUKE Large shareholder
293,015 -7.0%
0.30
US$87,904 		293,015 -7.0% 0.30 US$87,904
2012-06-04 2012-05-23 S Sale MPM BIOVENTURES III-QP L.P. Large shareholder
135,250 -3.1%
0.30
US$40,629 		135,250 -3.1% 0.30 US$40,629
2012-06-04 2012-05-23 S Sale EVNIN LUKE Large shareholder
135,250 -3.1%
0.30
US$40,629 		135,250 -3.1% 0.30 US$40,629
2012-06-04 2012-05-22 S Sale MPM BIOVENTURES III-QP L.P. Large shareholder
287,000 -6.2%
0.30
US$86,990 		287,000 -6.2% 0.30 US$86,990
2012-06-04 2012-05-22 S Sale EVNIN LUKE Large shareholder
287,000 -6.2%
0.30
US$86,990 		287,000 -6.2% 0.30 US$86,990
2011-06-13 2011-06-10 B Purchase Pascoe Richard W

President and CEO

Executive Director
11,100 +5.6%
2.25
US$24,943 		11,100 +5.6% 2.25 US$24,943
2011-01-05 2011-01-03 S Sale MAST ERLE T Non-Executive Director
10,000 -15.0%
3.23
US$32,340 		10,000 -15.0% 3.23 US$32,340
2010-09-15 2010-09-15 B Purchase Nguyen Tran

Vice President and CFO

Officer
2,500 +10.0%
3.89
US$9,725 		2,500 +10.0% 3.89 US$9,725
2010-09-03 2010-09-01 PlS Planned sale Dorsey Brian

SVP, Technical Operations

Officer
3,000 -5.5%
4.27
US$12,810 		3,000 -5.5% 4.27 US$12,810
2010-08-27 2010-08-25 PlS Planned sale Dorsey Brian

SVP, Technical Operations

Officer
5,000 -8.8%
4.99
US$24,950 		5,000 -8.8% 4.99 US$24,950
2010-08-13 2010-08-10 PlS Planned sale Dorsey Brian

SVP, Technical Operations

Officer
3,000 -5.5%
3.99
US$11,970 		3,000 -5.5% 3.99 US$11,970
2010-07-16 2010-07-15 PlS Planned sale Dorsey Brian

SVP, Technical Operations

Officer
3,000 -5.5%
3.99
US$11,970 		3,000 -5.5% 3.99 US$11,970
2010-06-25 2010-06-24 PlS Planned sale Dorsey Brian

SVP, Technical Operations

Officer
3,795 -100.0%
4.48
US$17,013 		3,795 -100.0% 4.48 US$17,013
2010-06-25 2010-06-24 PlS Planned sale Dorsey Brian

SVP, Technical Operations

Officer
1,392 -100.0%
4.48
US$6,240 		1,392 -100.0% 4.48 US$6,240
2010-06-25 2010-06-24 PlS Planned sale Dorsey Brian

SVP, Technical Operations

Officer
1,833 -100.0%
4.48
US$8,217 		1,833 -100.0% 4.48 US$8,217
2010-06-25 2010-06-24 PlS Planned sale Dorsey Brian

SVP, Technical Operations

Officer
1,412 -100.0%
4.48
US$6,330 		1,412 -100.0% 4.48 US$6,330
2010-06-25 2010-06-24 PlS Planned sale Dorsey Brian

SVP, Technical Operations

Officer
354 -100.0%
4.48
US$1,587 		354 -100.0% 4.48 US$1,587
2010-06-25 2010-06-24 PlS Planned sale Dorsey Brian

SVP, Technical Operations

Officer
214 -100.0%
4.48
US$959 		214 -100.0% 4.48 US$959
2010-03-22 2010-03-18 PlS Planned sale Dorsey Brian

VP Product Development

Officer
500 -5.0%
9.74
US$4,868 		500 -5.0% 9.74 US$4,868
2010-03-22 2010-03-18 PlS Planned sale Dorsey Brian

VP Product Development

Officer
2,800 -22.0%
8.78
US$24,596 		2,800 -22.0% 8.78 US$24,596
2010-03-22 2010-03-18 PlS Planned sale Dorsey Brian

VP Product Development

Officer
15,900 -55.6%
7.92
US$125,947 		15,900 -55.6% 7.92 US$125,947
2010-03-22 2010-03-18 PlS Planned sale Dorsey Brian

VP Product Development

Officer
15,800 -35.6%
6.67
US$105,323 		15,800 -35.6% 6.67 US$105,323
2010-03-22 2010-03-18 PlS Planned sale Dorsey Brian

VP Product Development

Officer
23,000 -34.1%
5.23
US$120,262 		23,000 -34.1% 5.23 US$120,262
2010-03-22 2010-03-18 PlS Planned sale Onaitis Matthew

VP, General Counsel

Officer
14,454 -32.5%
9.00
US$130,086 		14,454 -32.5% 9.00 US$130,086
2010-03-22 2010-03-18 PlS Planned sale Onaitis Matthew

VP, General Counsel

Officer
15,000 -25.2%
6.59
US$98,882 		15,000 -25.2% 6.59 US$98,882
2010-03-22 2010-03-18 S Sale MONTREUX EQUITY PARTNERS II SBIC LP Large shareholder
1,500,000 -68.3%
6.38
US$9,573,600 		1,500,000 -68.3% 6.38 US$9,573,600
2010-03-19 2010-03-18 S Sale Raser Jeffrey

Senior VP, Sales and Marketing

Officer
1,200 -7.4%
9.74
US$11,682 		1,200 -7.4% 9.74 US$11,682
2010-03-19 2010-03-18 S Sale Raser Jeffrey

Senior VP, Sales and Marketing

Officer
6,800 -29.6%
8.82
US$60,004 		6,800 -29.6% 8.82 US$60,004
2010-03-19 2010-03-18 S Sale Raser Jeffrey

Senior VP, Sales and Marketing

Officer
7,500 -24.6%
7.84
US$58,822 		7,500 -24.6% 7.84 US$58,822
2010-03-19 2010-03-18 S Sale Raser Jeffrey

Senior VP, Sales and Marketing

Officer
24,500 -44.5%
6.57
US$161,053 		24,500 -44.5% 6.57 US$161,053
2010-03-19 2010-03-18 PlS Planned sale Raser Jeffrey

Senior VP, Sales and Marketing

Officer
230 -1.5%
9.75
US$2,243 		230 -1.5% 9.75 US$2,243
2010-03-19 2010-03-18 PlS Planned sale Raser Jeffrey

Senior VP, Sales and Marketing

Officer
2,100 -12.1%
8.84
US$18,571 		2,100 -12.1% 8.84 US$18,571
2010-03-19 2010-03-18 PlS Planned sale Raser Jeffrey

Senior VP, Sales and Marketing

Officer
2,400 -12.2%
7.81
US$18,753 		2,400 -12.2% 7.81 US$18,753
2010-03-19 2010-03-18 S Sale Pascoe Richard W

President and CEO

Executive Director
1,200 -7.2%
9.58
US$11,491 		1,200 -7.2% 9.58 US$11,491
2010-03-19 2010-03-18 S Sale Pascoe Richard W

President and CEO

Executive Director
2,600 -13.5%
8.74
US$22,719 		2,600 -13.5% 8.74 US$22,719
2010-03-19 2010-03-18 S Sale Pascoe Richard W

President and CEO

Executive Director
4,800 -19.9%
7.53
US$36,156 		4,800 -19.9% 7.53 US$36,156
2010-03-19 2010-03-18 S Sale Pascoe Richard W

President and CEO

Executive Director
15,100 -38.5%
6.42
US$96,928 		15,100 -38.5% 6.42 US$96,928
2010-03-19 2010-03-18 S Sale Pascoe Richard W

President and CEO

Executive Director
76,300 -66.1%
5.62
US$429,111 		76,300 -66.1% 5.62 US$429,111
2010-03-03 2010-03-01 PlS Planned sale Raser Jeffrey

Senior VP, Sales and Marketing

Officer
84,000 -100.0%
4.08
US$342,367 		84,000 -100.0% 4.08 US$342,367
2010-03-03 2010-03-01 PlS Planned sale Pascoe Richard W

President and CEO

Executive Director
40,000 -100.0%
4.01
US$160,524 		40,000 -100.0% 4.01 US$160,524
2010-03-03 2010-03-01 PlS Planned sale Onaitis Matthew

VP, General Counsel

Officer
30,000 -100.0%
4.02
US$120,465 		30,000 -100.0% 4.02 US$120,465
2010-03-02 2010-03-01 PlS Planned sale Dorsey Brian

VP Product Development

Officer
23,000 -100.0%
4.01
US$92,179 		23,000 -100.0% 4.01 US$92,179
2010-03-02 2010-02-26 PlS Planned sale Dorsey Brian

VP Product Development

Officer
6,000 -100.0%
3.99
US$23,940 		6,000 -100.0% 3.99 US$23,940
2010-02-09 2010-02-05 PlS Planned sale Dorsey Brian

VP Product Development

Officer
20,712 -100.0%
3.06
US$63,368 		20,712 -100.0% 3.06 US$63,368
2010-02-09 2010-02-05 PlS Planned sale Raser Jeffrey

Senior VP, Sales and Marketing

Officer
57,500 -100.0%
3.03
US$174,306 		57,500 -100.0% 3.03 US$174,306
2010-02-09 2010-02-05 PlS Planned sale Pascoe Richard W

President and CEO

Executive Director
62,000 -100.0%
3.03
US$187,600 		62,000 -100.0% 3.03 US$187,600
2010-02-09 2010-02-05 PlS Planned sale Onaitis Matthew

VP, General Counsel

Officer
60,000 -100.0%
3.03
US$181,506 		60,000 -100.0% 3.03 US$181,506
2009-12-18 2009-12-18 S Sale TREU JESSE I Non-Executive Director
61,308 -100.0%
1.10
US$67,439 		61,308 -100.0% 1.10 US$67,439
Explore more

More insider trading research around Somaxon Pharmaceuticals, Inc.

More insider trades in United States
Insider trading in North America